Your browser doesn't support javascript.
loading
Analysis of the effect of Sphingomyelinase on rubellavirus infectivity in two cell lines.
Otsuki, Noriyuki; Sakata, Masafumi; Mori, Yoshio; Okamoto, Kiyoko; Takeda, Makoto.
Afiliação
  • Otsuki N; Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
  • Sakata M; Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
  • Mori Y; Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
  • Okamoto K; Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
  • Takeda M; Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Bio Protoc ; 8(17): e2992, 2018 Sep 05.
Article em En | MEDLINE | ID: mdl-34395791
Rubella is a mildly contagious disease characterized by low-grade fever and a morbilliform rash caused by the rubella virus (RuV). Viruses often use cellular phospholipids for infection. We studied the roles of cellular sphingomyelin in RuV infection. Treatment of cells with sphingomyelinase (SMase) inhibited RuV infection in rabbit kidney-derived RK13 cells and African green monkey (Cercopithecus aethiops) kidney-derived Vero cells. Our data further demonstrated that RuV used cellular sphingomyelin and cholesterol for its binding to cells and membrane fusion at the step of virus entry. Detailed protocols of our assays, which assess the effects of SMase treatment on RuV infectivity in RK13 and Vero cells, are described.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article